Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
10/2012
10/04/2012US20120251547 Il-17 receptor a antigen binding proteins
10/04/2012US20120251517 Super fast-acting insulin compositions
10/04/2012US20120251511 Composition and products for enabling the production of equol in vivo
10/03/2012EP2505211A1 Molecules for targeting compounds to various selected organs or tissues
10/03/2012EP2504004A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina
10/03/2012CN1911205B Aqueous hair detergent
10/03/2012CN102711916A Use of an adrenal hormone-modifying agent
10/03/2012CN102711789A Therapeutic agents for reducing parathyroid hormone levels
10/03/2012CN102703295A Maca wine and production method thereof
10/03/2012CN102702355A Anti FGF23 antibody and a pharmaceutical composition comprising the same
10/03/2012CN102702330A Intermedin analogue prepared by bonding ring core sequence with biotin or cell-penetrating peptides
10/03/2012CN102698043A Medicinal combination for treating thyroid gland
10/03/2012CN102698025A Traditional Chinese medicine preparation for treating female endocrine dyscrasia and preparation method thereof
10/03/2012CN102697898A Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia
10/03/2012CN102697837A Method for extracting and separating total flavonoid from Medicago Sativa L.
10/03/2012CN102697821A Method for comprehensively utilizing desert parasitic plant cynomorium and product and application thereof
10/03/2012CN102697785A Methods for treating or preventing sysmptoms of hormonal variations
10/03/2012CN102266324B New application of kappa-opioid receptor agonist
10/03/2012CN101541823B Progesterone receptor antagonists
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012CA2321444C Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects
09/2012
09/27/2012WO2012127388A1 Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators
09/27/2012WO2012126901A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012US20120245552 Combination Therapy
09/27/2012US20120245202 Methods and products for treating inflammation
09/27/2012US20120245194 Small molecule inhibitors of the alpha4-paxillin interaction
09/27/2012US20120245146 Method of treatment of hormone depletion induced vasomotor
09/27/2012US20120245144 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012US20120245134 Androgen pharmaceutical composition and method for treating depression
09/27/2012US20120245083 Derivatives of CGRP
09/27/2012US20120245080 Mineral salt-sulfonic acid compositions and methods of use
09/27/2012US20120244216 Coated pharmaceutical capsule dosage form
09/27/2012US20120244148 Anti-interferon-alpha antibodies
09/27/2012CA2829466A1 Benzo [b] [1,4] oxazin derivatives as calcium sensing receptor modulators
09/27/2012CA2825966A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/26/2012EP2503005A2 Cortexolone-17alpha-propionate in cristalline hydrate form IV
09/26/2012EP2503004A1 Cortexolone-17alpha-propionate in crystalline form I
09/26/2012EP2502996A2 Anti-FGF23 antibody and pharmaceutical composition comprising the same
09/26/2012CN102690259A Compound with function of diuresis, preparation method and functions thereof
09/26/2012CN102688387A Medicine for treating subacute thyroiditis
09/26/2012CN102145027B Pollen pini water extract for treating child sexual precocity, preparation method and use of pollen pini water extract
09/26/2012CN101912617B Application of MG53 gene to treatment of insulin resistance, type II diabetes mellitus and related diseases thereof
09/26/2012CN101128484B Compositions and methods relating to anti IGF-1 receptor antibodies
09/25/2012US8273740 antiallergen; not direct way to change nature of immunological response to allergen; G-protein-coupled "chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)" antagonist for prostaglandin PGD2, that mediates PGD2-dependent migration of blood Th2 cells; ; asthma, rhinitis, COPD
09/25/2012US8273728 Preformulation for tabletting natural mixtures of conjugated estrogens
09/25/2012CA2538939C Selective estrogen receptor modulators
09/20/2012WO2012124649A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
09/20/2012WO2012123820A1 Combination of anti-clusterin oligonucleotide with androgen receptor antagonist for the treatment of prostate cancer
09/20/2012WO2012123493A2 Isoxazolidine derivatives
09/20/2012WO2012123482A2 Isoxazolidine derivatives
09/20/2012WO2012122930A1 Lhrh antagonist derivative, and preparation method and applications thereof
09/20/2012US20120238621 Oligomer-Calcimimetic Conjugates and Related Compounds
09/20/2012US20120238586 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120238545 Tricyclic pyrazol amine derivatives
09/20/2012US20120238544 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
09/20/2012US20120238540 Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1
09/20/2012US20120238534 Oral suspension of prednisolone acetate
09/20/2012US20120238510 Crystalline form of benzylbenzene sglt2 inhibitor
09/20/2012US20120238499 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
09/20/2012US20120237972 Mammalian-type glycosylation in plants
09/20/2012US20120237666 Preformulation for Tabletting Natural Mixtures of Conjugated Estrogens
09/20/2012US20120237570 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
09/20/2012US20120237516 Compositions and methods relating to anti-igf-1 receptor antibodies
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120237472 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
09/20/2012US20120237442 Design and Construction of Novel Multivalent Antibodies
09/20/2012CA2850081A1 Isoxazolidine derivatives
09/20/2012CA2830191A1 Combination of anti-clusterin oligonucleotide with androgen receptor antagonist for the treatment of prostate cancer
09/20/2012CA2829982A1 Isoxazolidine derivatives
09/20/2012CA2827629A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
09/19/2012EP2500345A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/19/2012EP2500062A2 C-19 steroids for specific therapeutic uses
09/19/2012EP2499135A1 Androgen receptor modulator and uses thereof
09/19/2012CN102686590A Pyrazoline dione derivatives as NADPH oxidase inhibitors
09/19/2012CN102675467A Fusion protein of human somatostatin 28 peptide and human serum albumin, encoding gene of fusion protein and preparation method for fusion protein
09/19/2012CN102675453A Adrenocorticotrophic hormone (ACTH) analogue, preparation method and application thereof
09/19/2012CN102675418A Luteinizing hormone-releasing hormone (LHRH) antagonist derivative, preparation method of LHRH antagonist derivative and application of LHRH antagonist derivative
09/19/2012CN102675395A Polycrystal forms of ulipristal acetate and preparation method thereof
09/19/2012CN102675380A Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate
09/19/2012CN102675316A Quinazoline purine derivative and application thereof in preparation of diabetes drugs
09/19/2012CN102675299A Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate
09/19/2012CN102671185A Application of scolopendra mutilans neurotoxin peptide omega-SLPTX-Ssmla
09/19/2012CN102670673A Application of active ingredients of gumbo in preparation of medicaments for preventing and treating metabolic diseases
09/19/2012CN102670582A Inhibitory activity of norathyriol to protein tyrosine phosphatase 1B (PTP1B) and application thereof
09/19/2012CN102091068B Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (SARMS)
09/19/2012CN101745013B Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof
09/19/2012CN101745012B Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof
09/19/2012CN101745011B Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof
09/19/2012CN101745004B Method for extracting radix ophiopogonis, ginseng and schisandra chinensis as well as preparation thereof
09/19/2012CN101745003B Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
09/19/2012CN101745002B Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
09/19/2012CN101745001B Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
09/19/2012CN101745000B Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
09/19/2012CN101421290B 17-phosphorous steroid derivatives useful as progesterone receptor modulators
09/19/2012CN101278079B 药物设计方法 Drug Design Methods
09/18/2012US8268842 Fused ring 4-oxopyrimidine derivative
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268829 Substituted pyrimidines useful as protein kinase inhibitors
09/18/2012US8268351 time-release agents comprising water-swellable matrix cores containing estrogen derivative extracted from animals surrounded by film-forming coatings
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 290